Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1026 of 5804
-
New shot could ease stuffy noses and polyps for sinusitis sufferers
Disease control Not yet recruitingThis is an open-label, single-arm, multicenter, extension study to evaluate the safety and efficacy of CM512 in patients With Chronic Rhinosinusitis with Nasal Polyposis
Phase: PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Bee glue and sound waves: new hope for diabetic wounds?
Disease control Not yet recruitingThis study aims to evaluate whether using ultrasound (phonophoresis) can help deliver propolis-a natural compound made by bees-more effectively into the skin to speed up wound healing in people with diabetic foot ulcers. Diabetic foot ulcers are a common and serious complication …
Phase: NA • Sponsor: Sinai University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Parkinson's patients try VR to stay steady on their feet
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether immersive virtual reality (VR)-based physiotherapy is effective in improving balance, reducing fall risk, and enhancing cardiorespiratory exercise capacity in individuals with Parkinson's disease. The main questions it aims t…
Phase: NA • Sponsor: University of Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New modular implants aim to rebuild bones lost to cancer or injury
Disease control Not yet recruitingMassive prostheses are the standard treatment for extensive bone loss, whether caused by cancer or other factors (complex fractures, multiple revisions, infections). The emergence of modular systems such as the Pantheon range provides rapid restoration of function and precise in…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Experimental cell therapy targets kidney disease
Disease control Not yet recruitingThis study is a single-arm, open-label, dose-escalation and dose-expansion clinical trial, divided into two phases: the first phase is the dose-escalation phase, and the second phase is the dose-expansion phase. In the dose-escalation phase, approximately 9-18 adult participants …
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kidney cancer patients with bone spread: drug combo trial launches
Disease control Not yet recruitingThis is a single-institution, phase 2 trial of zanzalintinib plus investigator-choice bone-strengthening agent in patients with metastatic renal cell carcinoma (RCC) with bone metastases whose disease has advanced on 1-3 prior lines of therapy, including at least one immune oncol…
Phase: PHASE2 • Sponsor: Kelly Fitzgerald, MD • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for lung cancer patients with brain-spread disease
Disease control Not yet recruitingA Prospective Study of Zorifertinib Combined with Intra-Ommaya Reservoir Cerebrospinal Fluid Chemotherapy for Leptomeningeal Progression in NSCLC Patients After Third-Generation EGFR-TKI Therapy
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New chemo combo aims to stop liver cancer return after surgery
Disease control Not yet recruitingThis is a prospective, single-center, single-arm exploratory clinical study designed to evaluate the efficacy and safety of hepatic arterial infusion of liposomal irinotecan combined with systemic oxaliplatin and capecitabine as postoperative adjuvant therapy in patients with col…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
AI could slash wait times for hearing and tinnitus care
Diagnosis Not yet recruitingHearing loss affects approximately 11 million people in the UK, while tinnitus impacts around 7 million. Both conditions can significantly reduce quality of life and are linked to poorer mental health and employment challenges. Each year, tinnitus alone accounts for more than one…
Sponsor: Royal Cornwall Hospitals Trust • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New ultrasound contrast agent could spot liver cancer sooner
Diagnosis Not yet recruitingThis study is a multicenter, prospective study. In this study, enrolled subjects are cirrhotic patients of any etiology. The US and Sonazoid CEUS monitoring strategy was performed for cirrhotic patients: US and AFP joint with Sonazoid CEUS every 4 to 6 months, and combined CECT/C…
Phase: NA • Sponsor: Tianjin Third Central Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
New hope for kids with seizures: cenobamate trial launches
Disease control Recruiting nowPrimary objective: To evaluate the safety and tolerability of cenobamate in Japanese pediatric subjects 2-17 years of age with partial-onset (focal) seizures
Phase: PHASE3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New combo aims to shrink bile duct tumors before surgery
Disease control Not yet recruitingThis trial is to evaluate the efficacy of Gemcitabine-Cisplatin (GC) plus Envafolimab neoadjuvant therapy in the patients at high risk of recurrence. Primary endpoint: Major Pathologic Response (MPR). It will also learn about the safety of drug including Gemcitabine-Cisplatin (GC…
Phase: PHASE2 • Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New dosing strategy aims to help breast cancer patients stick with treatment
Disease control Not yet recruitingAbemaciclib combined with endocrine therapy has become one of the important adjuvant treatment regimens for patients with HR+/HER2- high-risk early breast cancer. However, adverse events such as diarrhea, fatigue, neutropenia and elevated liver enzymes are concentrated in the ear…
Phase: PHASE4 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis study aims to evaluate the safety, tolerability, PK characteristics, immunogenicity, and preliminary anti-tumor efficacy of SCTB41 in combination with SCTB39-1with or without standard therapy in adult patients with advanced malignant solid tumours. This study is an open labe…
Phase: PHASE1, PHASE2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could gentle brain zaps ease depression? new trial investigates
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether transcranial temporal interference stimulation (tTIS) can help treat major depressive disorder (MDD) in adults. The study will also learn about the safety of tTIS and explore how it may affect brain structure and brain function.…
Phase: NA • Sponsor: Yonggui Yuan • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Can a vitamin a drug boost platelets in Hard-to-Treat ITP?
Disease control Not yet recruitingA multicenter, randomized, double-blind placebo-controlled study to report the efficacy and safety of all-trans etinoic acid compared to placebo for the treatment of adults with corticosteriod-resistant/relapsed primary immune thrombocytopenia (ITP).
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a daily pill tame advanced breast cancer? new trial tests oral paclitaxel
Disease control Not yet recruitingThe goal of this clinical trial is to learn if oral paclitaxel solution (metronomic scheduling) works to treat advanced HER2-negative breast cancer in adults. It will also learn about the safety of oral paclitaxel solution alone and combined with toripalimab. The main questions …
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for amputees: botox may beat standard pain shots for nerve pain
Symptom relief Not yet recruitingPatients with combat-related amputations frequently experience persistent neuroma pain that may interfere with rehabilitation, prosthesis use, sleep, mobility, and quality of life. Current treatment options often provide only temporary relief. This study aims to compare two ultra…
Phase: NA • Sponsor: Ukrainian Society of Regional Anesthesia and Pain Therapy • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Heart drug showdown: new combo pill vs old standard in kids
Disease control Not yet recruitingThis is a prospective, cohort study designed to evaluate the efficacy and safety of sacubitril/valsartan versus captopril in children with dilated cardiomyopathy (DCM) admitted to Assiut University Children Hospital over a one-year period.
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Ancient movements take on Parkinson's: tai chi and Qi-Gong face off
Disease control Recruiting nowThis study has important clinical, academic, and practical relevance in neuromuscular rehabilitation. Clinically, it aims to identify effective and tolerable rehabilitation strategies for individuals with Parkinson's disease by comparing Tai Chi Therapy with Qi-Gong there by supp…
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC